UK child vaccine schedule and moving to England

Document: gov.uk page last updated 24 Sep 2026.

The gov.uk page for the schedule is addressed to health professionals and immunisation practitioners; it was last updated 24 September 2026 and carries the schedule "from 1 September 2026".

Some UK entries repeat instructions written for the clinician giving the vaccine; they are quoted as the UKHSA prints them, not as advice to parents.

• From 1 January 2026 the MMRV vaccine is offered as part of the updated routine schedule, with an appointment at 18 months
• At eight weeks old the schedule lists DTaP/IPV/Hib/HepB (diphtheria, tetanus, pertussis, polio, Hib, hepatitis B; Infanrix hexa or Vaxelis, thigh), MenB (Bexsero, thigh) and rotavirus (Rotarix, by mouth; check the SCID screening result before giving)
• At twelve weeks old the schedule lists DTaP/IPV/Hib/HepB (Infanrix hexa or Vaxelis, thigh), MenB (Bexsero, thigh) and rotavirus (Rotarix, by mouth; check the SCID screening result before giving)
• At sixteen weeks old the schedule lists DTaP/IPV/Hib/HepB (Infanrix hexa or Vaxelis, thigh) and pneumococcal, 13 serotypes (PCV, Prevenar 13, thigh)
• At one year old (on or after the first birthday) the schedule lists pneumococcal (PCV, Prevenar 13), MenB (Bexsero) and measles, mumps, rubella, varicella (MMRV, ProQuad or Priorix Tetra); upper arm or thigh
• At eighteen months old, for children born on or after 1 July 2024 the schedule lists DTaP/IPV/Hib/HepB (Infanrix hexa or Vaxelis) and MMRV (ProQuad or Priorix Tetra), upper arm or thigh; for children born on or before 30 June 2024 it says "No appointment"
• At three years four months old or soon after, for children born on or after 1 January 2025 the schedule lists dTaP/IPV (REPEVAX; diphtheria, tetanus, pertussis and polio); for children born on or before 31 December 2024 it lists dTaP/IPV and MMRV (REPEVAX; ProQuad or Priorix Tetra); upper arm
• Boys and girls aged twelve to thirteen years: HPV vaccine (Gardasil 9; cancers and genital warts caused by specific HPV types), upper arm
• At fourteen years old (school Year 9): Td/IPV (check MMR status; REVAXIS) and MenACWY (MenQuadfi), upper arm
• Influenza: an "eligible paediatric age group" is listed for the live attenuated influenza vaccine (Fluenz, both nostrils), each year from September, with inactivated flu vaccine if LAIV is contraindicated or unsuitable (check Green Book Chapter 19 for details); Fluenz is marked as containing porcine gelatine; the page sends readers to the annual flu letter for which ages
• Selective programmes for infants: hepatitis B at birth and four weeks for babies born to women with hepatitis B infection (Engerix B/HBvaxPRO; for these babies take blood for HBsAg anytime between 12 and 18 months to test for infection, and hexavalent vaccine (Infanrix hexa or Vaxelis) is given in addition at 8, 12 and 16 weeks and also at 18 months); BCG within 28 days of birth for infants in areas with TB incidence of 40 per 100,000 or more, and for infants with a parent or grandparent born in a high incidence country (check the SCID screening outcome before giving BCG); "high incidence" means annual TB incidence of 40 per 100,000 or more

Source: gov.uk